Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:607-608
doi: 10.1161/CIRCULATIONAHA.108.190520
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;118:607-608.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion
 
Cardiac arrhythmia is a potentially life-threatening complication of heart failure and ischemic heart disease. In the past, some therapeutic approaches for both of these conditions were associated with an increased risk of arrhythmia and/or sudden cardiac death. Previous work in a variety of animal models has demonstrated that enhancing sarcoplasmic reticulum calcium uptake through expression of the sarcoplasmic reticulum ATPase (SERCA2a) can improve cardiac contractile function, survival, and the energetic state. Here, we demonstrate in a preclinical large animal model that, in contrast to some pharmacological agents that improve inotropy but increase electric instability, SERCA2a expression actually reduces arrhythmia as a result of calcium overload. These findings support the notion that enhancing sarcoplasmic reticulum calcium uptake may hold promise for the prevention and treatment of arrhythmia for reperfusion and heart failure. See p 614.


*    Tumor Necrosis Factor-{alpha} and Mortality in Heart Failure: A Community Study
 
Mortality among patients with heart failure is high. Interest has risen recently in the use of biomarkers to aid in identifying heart failure patients at increased mortality risk. Tumor necrosis factor-{alpha} (TNF{alpha}), an inflammatory cytokine, has previously been reported to be elevated in heart failure clinical trial patients with reduced ejection fraction and associated with increased mortality. However, data on patients with preserved EF and those living in the community were lacking. Among community heart failure patients with both preserved and reduced ejection fraction, our study findings indicate that TNF{alpha} is elevated in 29% of patients and that higher levels are more common in patients with increased comorbidity, including renal insufficiency and anemia. Higher . . . [Full Text of this Article]


Related Articles:

Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular Injury
Brandon M. Proctor, Xiaohua Jin, Traian S. Lupu, Louis J. Muglia, Clay F. Semenkovich, and Anthony J. Muslin
Circulation 2008 118: 658-666. [Abstract] [Full Text]

Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry
Allen Jeremias, Neal S. Kleiman, Deborah Nassif, Wen-Hua Hsieh, Michael Pencina, Kelly Maresh, Manish Parikh, Donald E. Cutlip, Ron Waksman, Steven Goldberg, Peter B. Berger, David J. Cohen for the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators
Circulation 2008 118: 632-638. [Abstract] [Full Text]

Tumor Necrosis Factor-{alpha} and Mortality in Heart Failure: A Community Study
Shannon M. Dunlay, Susan A. Weston, Margaret M. Redfield, Jill M. Killian, and Véronique L. Roger
Circulation 2008 118: 625-631. [Abstract] [Full Text]

Increased Cardiac Myocyte Progenitors in Failing Human Hearts
Hajime Kubo, Naser Jaleel, Asangi Kumarapeli, Remus M. Berretta, George Bratinov, Xiaoyin Shan, Hongmei Wang, Steven R. Houser, and Kenneth B. Margulies
Circulation 2008 118: 649-657. [Abstract] [Full Text]

Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation
Massimo Imazio, Antonio Brucato, Davide Cumetti, Giovanni Brambilla, Brunella Demichelis, Silvia Ferro, Silvia Maestroni, Enrico Cecchi, Riccardo Belli, Giancarlo Palmieri, and Rita Trinchero
Circulation 2008 118: 667-671. [Abstract] [Full Text]

Predictors of Outcome in Patients With Suspected Myocarditis
Ingrid Kindermann, Michael Kindermann, Reinhard Kandolf, Karin Klingel, Burkhard Bültmann, Thomas Müller, Angelika Lindinger, and Michael Böhm
Circulation 2008 118: 639-648. [Abstract] [Full Text]

Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion
Fabrice Prunier, Yoshiaki Kawase, Davide Gianni, Cristina Scapin, Stephan B. Danik, Patric T. Ellinor, Roger J. Hajjar, and Federica del Monte
Circulation 2008 118: 614-624. [Abstract] [Full Text]